Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-022205

SVP, Diagnostics, immunoSEQ Dx sold 16,052 shares at an average $43.58 ($699,560)

  • SVP, Diagnostics, immunoSEQ Dx acquired 16,052 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx 2021-03-18 Option exercise +16,052 $22.55 $361,973 25,210 D: show line 1 in the form
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx 2021-03-18 Sale −8,342 $43.04 $359,040 16,868 D: show line 2 in the form
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx 2021-03-18 Sale −5,971 $43.83 $261,709 10,897 D: show line 3 in the form
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx 2021-03-18 Sale −1,739 $45.32 $78,811 9,158 D: show line 4 in the form
Open-market sales · 16,052 sh · avg $43.58 · $699,560

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx 2021-03-18 Option exercise · Stock Option (Right to Buy) −16,052 108,948 D: show line 5 in the form
Loading xslF345X03/doc4.xml…